Results 31 to 40 of about 7,331 (198)

Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High‐Fidelity Cardiovascular Phenotyping

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundSympathetic and parasympathetic influences on heart rate (HR), which are governed by baroreflex mechanisms, are integrated at the cardiac sinus node through hyperpolarization‐activated cyclic nucleotide–gated channels (HCN4).
Karsten Heusser, Jens Tank, Julia Brinkmann, Christoph Schroeder, Marcus May, Anika Großhennig, Daniela Wenzel, André Diedrich, Fred C. G. J. Sweep, Heidrun Mehling, Friedrich C. Luft, Jens Jordan   +11 more
doaj   +1 more source

The role of ivabradine and beta blockers in the treatment of cardiovascular diseases

, 2021
The thesis is on the development and history of ivabradine and its uses on cardiovascular diseases. It also compared it against beta blockers and how they work and interact on certain diseases.
Mungur, Asad Fawzi
core  

Rate control with ivabradine

, 2011
The importance of heart rate in human health and disease has been well known to clinicians for quite some time. Recent epidemiologic studies have further strengthened this concept.
Balram Bhargava, Neeraj Parakh, Parakh, Neeraj, Bhargava, Balram   +3 more
core   +1 more source

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease [PDF]

, 2012
<p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among ...
Abergel, Helene, Jean Claude Tardif, Roberto Ferrari (43159), Tardif, Jean-Claude, Kim M. Fox (166687), Greenlaw Nicola, Nicola Greenlaw (166677), Fox, KM, Tendera, Michal, Ph. Gabriel Steg (166673), Abergel Hélène, For The Clarify Investigators, Tardif, J-C., Ian Ford, Ford Ian, González Juanatey, Carlos, Tendera Michal, Ph. Gabriel Steg, Michal Tendera (166680), Kim M. Fox, I. Ford, Steg Ph. Gabriel, Steg, PG, Ian Ford (30666), Greenlaw, N, Jean-Claude Tardif (79699), Fox Kim M., H. Abergel, Nicola Greenlaw, Colquhoun, David, Ford, Ian, Ferrari Roberto, Tendera, M., Ford, I, Ferrari, R., K. M. Fox, Abergel, H., Abergel, H, Ford, I., Fox, Kim M., Michal Tendera, Jean-Claude Tardif, Greenlaw, Nicola, R. Ferrari, Tendera, M, N. Greenlaw, Ferrari, Roberto, Hélène Abergel (166683), M. Tendera, Tardif Jean-Claude, Hélène Abergel, P.h. Gabriel Steg, Fox, K., Greenlaw, N., CLARIFY Investigators, Roberto Ferrari, M. Turiel, Ph Gabriel Steg, P. G. Steg, Tardif, J-C, Steg, P.G., Steg, Ph Gabriel, Ferrari, R, J. C. Tardif, Kim M Fox   +64 more
core   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Clinical use of ivabradine in the acute coronary syndrome: A systematic review and narrative synthesis of current evidence

American Heart Journal Plus, 2022
Heart rate (HR) lowering during acute coronary syndrome (ACS) is beneficial as it reduces myocardial oxygen consumption. However, the role of ivabradine as an HR-lowering agent in the setting of ACS is not clear.
Josip A. Borovac, Martin Kowalski, Tina Poklepovic Pericic, Marin Vidak, Konstantin Schwarz, Domenico D'Amario, Dino Miric, Duska Glavas, Josko Bozic   +8 more
doaj   +1 more source

Treatment of inappropriate sinus tachycardia with ivabradine

, 2015
Background: Inappropriate sinus tachycardia (IST) often causes palpitations, dyspnea, and exercise intolerance, that are generally treated with beta blockers and non-dihydropyridine calcium-channel antagonists.
de Ambroggi, Guido, MARTINO, ANNAMARIA, Foresti, Sara, de Ruvo, Ermenegildo, Calo, Leonardo, Lupo, Pier Paolo, Sciarra, Luigi, Cappato, Riccardo   +7 more
core   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Ivabradine and endothelium: an update [PDF]

Therapeutic Advances in Cardiovascular Disease, 2020
Ivabradine is a pure heart-rate lowering drug that is nowadays used, accordingly to the last ESC Guidelines, to reduce mortality and heart failure (HF) hospitalization in patients with HF with reduced ejection fraction and in symptomatic patiens with inappropriate sinus tachycardia.
Lucia Dallapellegrina, Edoardo Sciatti, Enrico Vizzardi   +2 more
openaire   +4 more sources

Ivabradine in Heart Failure

, 2017
Background: The sinus node inhibitor ivabradine was approved for patients with heart failure (HF) after the ivabradine and outcomes in chronic HF (SHIFT [Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial ...
Das, D., Ulf Dahlström, Justin A. Ezekowitz, Howlett, Jonathan,, Dahlstrom, U, Das, D, Lund, LH, Savarese, G,, Debraj Das, Fu, M, Lund, Lars H.,, Savarese, G., Gianluigi Savarese, Howlett, J, Michael Fu, Ezekowitz, Justin A.,, Ezekowitz, J. A., Lars H. Lund, Fu, Michael,, Jonathan Howlett, Das, Debraj,, Lund, L. H., Howlett, J., Dahlstrom, U., Dahlström, Ulf,, Savarese, Gianluigi,, Ezekowitz, JA   +26 more
core   +1 more source